Janux Therapeutics, Inc. (JANX)

Healthcare · Biotechnology · NASDAQ

Janux Therapeutics, Inc. (JANX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.02B and a free-cash-flow yield of -8.0%. Over the most recent reported fiscal year, revenue declined 5.5%.

Market cap	$1.02B
Trailing P/E	—
FCF yield	-8.0%
Revenue growth (YoY)	-5.5%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live JANX data on Nama Insights →